Novartis AG (NVS) | Profitability Analysis
Profitability ratios measure the company's ability to generate profitable sales from its resources (assets).
Ratios (Summary)
You have visited 10 password protected pages for free. Others contain data covered by 
.
Sign Up Now to get full access to whole website and cut out all advertisements.
Novartis AG, profitability ratios
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | ||
|---|---|---|---|---|---|---|
| Return on Sales | ||||||
| Gross profit margin | % |
% |
% |
% |
% |
|
| Operating profit margin | % |
% |
% |
% |
% |
|
| Net profit margin | % |
% |
% |
% |
% |
|
| Return on Investment | ||||||
| Return on equity (ROE) | % |
% |
% |
% |
% |
|
| Return on assets (ROA) | % |
% |
% |
% |
% |
|
Source: Based on data from Novartis AG Annual Reports
| Ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Novartis AG's gross profit margin deteriorated from 2010 to 2011 and from 2011 to 2012. |
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Novartis AG's operating profit margin deteriorated from 2010 to 2011 but then slightly improved from 2011 to 2012. |
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Novartis AG's net profit margin deteriorated from 2010 to 2011 but then slightly improved from 2011 to 2012. |
| ROE | A profitability ratio calculated as net income divided by shareholders' equity. | Novartis AG's ROE deteriorated from 2010 to 2011 and from 2011 to 2012. |
| ROA | A profitability ratio calculated as net income divided by total assets. | Novartis AG's ROA deteriorated from 2010 to 2011 and from 2011 to 2012. |
ADVERTISEMENT
Gross Profit Margin
You have visited 10 password protected pages for free. Others contain data covered by .
Sign Up Now to get full access to whole website and cut out all advertisements.
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (USD $ in millions) | ||||||
| Gross profit | |
|
|
|
|
|
| Net sales | |
|
|
|
|
|
| Gross profit margin1 | % |
% |
% |
% |
% |
|
Source: Based on data from Novartis AG Annual Reports
2012 Calculations
1 Gross profit margin = 100 × Gross profit ÷ Net sales
= 100 × ÷ = %
| Ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Novartis AG's gross profit margin deteriorated from 2010 to 2011 and from 2011 to 2012. |
ADVERTISEMENT
Operating Profit Margin
You have visited 10 password protected pages for free. Others contain data covered by .
Sign Up Now to get full access to whole website and cut out all advertisements.
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (USD $ in millions) | ||||||
| Operating income | |
|
|
|
|
|
| Net sales | |
|
|
|
|
|
| Operating Profit Margin, Comparison to Industry | ||||||
| Novartis AG1 | % |
% |
% |
% |
% |
|
| Industry, Health Care | % |
% |
% |
% |
% |
|
Source: Based on data from Novartis AG Annual Reports
2012 Calculations
1 Operating profit margin = 100 × Operating income ÷ Net sales
= 100 × ÷ = %
| Ratio | Description | The company |
|---|---|---|
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Novartis AG's operating profit margin deteriorated from 2010 to 2011 but then slightly improved from 2011 to 2012. |
ADVERTISEMENT
Net Profit Margin
You have visited 10 password protected pages for free. Others contain data covered by .
Sign Up Now to get full access to whole website and cut out all advertisements.
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (USD $ in millions) | ||||||
| Net income attributable to shareholders of Novartis AG | |
|
|
|
|
|
| Net sales | |
|
|
|
|
|
| Net Profit Margin, Comparison to Industry | ||||||
| Novartis AG1 | % |
% |
% |
% |
% |
|
| Industry, Health Care | % |
% |
% |
% |
% |
|
Source: Based on data from Novartis AG Annual Reports
2012 Calculations
1 Net profit margin = 100 × Net income attributable to shareholders of Novartis AG ÷ Net sales
= 100 × ÷ = %
| Ratio | Description | The company |
|---|---|---|
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Novartis AG's net profit margin deteriorated from 2010 to 2011 but then slightly improved from 2011 to 2012. |
ADVERTISEMENT
Return on Equity (ROE)
You have visited 10 password protected pages for free. Others contain data covered by .
Sign Up Now to get full access to whole website and cut out all advertisements.
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (USD $ in millions) | ||||||
| Net income attributable to shareholders of Novartis AG | |
|
|
|
|
|
| Issued share capital and reserves attributable to Novartis AG shareholders | |
|
|
|
|
|
| ROE, Comparison to Industry | ||||||
| Novartis AG1 | % |
% |
% |
% |
% |
|
| Industry, Health Care | % |
% |
% |
% |
% |
|
Source: Based on data from Novartis AG Annual Reports
2012 Calculations
1 ROE = 100 × Net income attributable to shareholders of Novartis AG ÷ Issued share capital and reserves attributable to Novartis AG shareholders
= 100 × ÷ = %
| Ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders' equity. | Novartis AG's ROE deteriorated from 2010 to 2011 and from 2011 to 2012. |
ADVERTISEMENT
Return on Assets (ROA)
You have visited 10 password protected pages for free. Others contain data covered by .
Sign Up Now to get full access to whole website and cut out all advertisements.
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (USD $ in millions) | ||||||
| Net income attributable to shareholders of Novartis AG | |
|
|
|
|
|
| Total assets | |
|
|
|
|
|
| ROA, Comparison to Industry | ||||||
| Novartis AG1 | % |
% |
% |
% |
% |
|
| Industry, Health Care | % |
% |
% |
% |
% |
|
Source: Based on data from Novartis AG Annual Reports
2012 Calculations
1 ROA = 100 × Net income attributable to shareholders of Novartis AG ÷ Total assets
= 100 × ÷ = %
| Ratio | Description | The company |
|---|---|---|
| ROA | A profitability ratio calculated as net income divided by total assets. | Novartis AG's ROA deteriorated from 2010 to 2011 and from 2011 to 2012. |
ADVERTISEMENT